Hospital Santa Caterina Ias

The medical center is at the forefront of research in maternal health, focusing on improving the quality of life for pregnant women experiencing nausea and vomiting of pregnancy (NVP). Through innovative clinical trials, the center evaluates the efficacy of novel therapeutic combinations, such as the fixed-dose combination of doxylamine and pyridoxine, to alleviate symptoms and enhance well-being during pregnancy.

• Nausea and Vomiting of Pregnancy (NVP)
• Quality of Life Improvements
• Modified-Release Therapeutics

By advancing treatment options for NVP, the center contributes significantly to the field of obstetrics, ensuring better health outcomes for both mothers and their unborn children.

Specializing in neurology, the medical center conducts pivotal research on relapsing multiple sclerosis (RMS). The institution is dedicated to evaluating the efficacy and tolerability of advanced treatments, such as ofatumumab, compared to first-line disease-modifying therapies (DMTs). This research aims to provide newly diagnosed patients with more effective and personalized treatment options.

• Relapsing Multiple Sclerosis (RMS)
• Advanced Disease-Modifying Therapies
• Patient-Centric Treatment Approaches

Through its commitment to cutting-edge research, the center plays a crucial role in enhancing therapeutic strategies for RMS, ultimately improving patient outcomes and quality of life.